Levodopa response in dementia with lewy bodies: A 1-year follow-up study

Parkinsonism and Related Disorders

Volumn 16, Issue 8, 2010, Pages 522-526

  Lucetti, Claudio ^a   Logi, Chiara ^b   Del Dotto, Paolo ^a   Berti, Caterina ^a   Ceravolo, Roberto ^b   Baldacci, Filippo ^b   Dolciotti, Cristina ^b   Gambaccini, Gianna ^b   Rossi, Giuseppe ^c   Bonuccelli, Ubaldo ^a,b  

^a Hospital of Viareggio   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Dementia with Lewy bodies; Parkinson's disease; Parkinsonism

Indexed keywords

CARBIDOPA PLUS LEVODOPA; CHOLINESTERASE INHIBITOR; CLOZAPINE; LEVODOPA;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HALLUCINATION; HUMAN; LATENT PERIOD; MALE; MOTOR DYSFUNCTION; MUSCLE RIGIDITY; PARKINSON DISEASE; PARKINSONISM; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROVOCATION TEST; TREATMENT DURATION; TREMOR; WALKING;

AGED; ANTIPARKINSON AGENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; LEWY BODY DISEASE; MALE; PARKINSON DISEASE;

EID: 77956175253     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.06.004     Document Type: Article

References (21)

1. Okazaki H., Lipkin L.E., Aronson S.M. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J Neuropathol Exp Neurol 1961, 20:237-244.
2. Hansen L.A., Masliah E., Galasko D., Terry R.D. Plaque-only Alzheimer disease is usually the Lewy body variant, and vice versa. J Neuropathol Exp Neurol 1993, 52(6):648-654.
3. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., et al. Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 2005, 65:1863-1872.
4. McKeith I.G. Dementia with Lewy bodies. Br J Psychiatry 2002, 180:144-147.
5. Poewe W. Treatment of dementia with Lewy bodies and Parkinson's disease dementia. Mov Disord 2005, 20(Suppl. 12):S77-S82.
6. Louis E.D., Klatka L.A., Liu Y., Fahn S. Comparison of extrapyramidal features in 31 pathologically confirmed cases of diffuse Lewy body disease and 34 pathologically confirmed cases of Parkinson's disease. Neurology 1997, 48:376-380.
7. Bonelli S.B., Ransmayr G., Steffelbauer M., Lukas T., Lampl C., Deibl M. l-dopa responsiveness in dementia with Lewy bodies, Parkinson disease with and without dementia. Neurology 2004, 63:376-378.
8. Molloy S., McKeith I.G., O'Brien J.T., Burn D.J. The role of levodopa in the management of dementia with Lewy bodies. J Neurol Neurosurg Psychiatr 2005, 76:1200-1203.
9. Gnanalingham K.K., Byrne E.J., Thornton A., Sambrook M.A., Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatr 1997, 62:243-252.
10. Goldman J.G., Goetz C.G., Brandabur M., Sanfilippo M., Stebbins G.T. Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies. Mov Disord 2008, 23:2248-2250.
11. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatr 1992, 55:181-184.
12. McKeith I.G., Burn D.J., Ballard C.G., Collerton D., Jaros E., Morris C.M., et al. Dementia with Lewy bodies. Semin Clin Neuropsychiatry 2003, 8:46-57.
13. Frank C. Dementia with Lewy bodies. Review of diagnosis and pharmacologic management. Can Fam Physician 2003, 49:1304-1311.
14. Papapetropoulos S., Lieberman A., Gonzalez J., Singer C., Laufer D.Z., Mash D.C. Family history of dementia: dementia with Lewy bodies and dementia in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2006, 18:113-116.
15. Geser F., Wenning G.K., Poewe W., McKeith I. How to diagnose dementia with Lewy bodies: state of the art. Mov Disord 2005, 20(Suppl. 12):S11-S20.
16. Aarsland D., Ballard C., McKeith I., Perry R.H., Larsen J.P. Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2001, 13:374-379.
17. Aarsland D., Andersen K., Larsen J.P., Lolk A., Kragh-Sørensen P. Prevalence and characteristics of dementia in Parkinson's disease: an 8-year prospective study. Arch Neurol 2003, 60:387-392.
18. Burn D.J., Rowan E.N., Minett T., Sanders J., Myint P., Richardson J., et al. Extrapyramidal features in Parkinson's disease with and without dementia and dementia with Lewy bodies: a cross-sectional comparative study. Mov Disord 2003, 18:884-889.
19. Piggott M.A., Marshall E.F., Thomas N., Lloyd S., Court J.A., Jaros E., et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain 1999, 122:1449-1468.
20. Joyce J.N., Ryoo H.L., Beach T.B., Caviness J.N., Stacy M., Gurevich E.V., et al. Loss of response to levodopa in Parkinson's disease and co-occurrence with dementia: role of D3 and not D2 receptors. Brain Res 2002, 955:138-152.
21. Yamamoto R., Iseki E., Marui W., Togo T., Katsuse O., Kato M., et al. Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies. Neuropathology 2005, 25:188-194.